Citation analysis for Occasional Papers / Office of Health Economics

Occasional Papers / Office of Health Economics

null

Impact Factor

0.2

5-Years IF

5-Years H index

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ]
[more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators

Raw data

	IF	AIF	IF5	DOC	CDO	CCU	CIF	CIT	D2Y	C2Y	D5Y	C5Y	%SC	CiY	II	AII
1990		0.11			0				0		0		(%)			0.06
1991		0.1			0				0		0		(%)			0.04
1992		0.1			0				0		0		(%)			0.05
1993		0.13			0				0		0		(%)			0.06
1994		0.14			0				0		0		(%)			0.06
1995		0.17			0				0		0		(%)			0.1
1996		0.22			0				0		0		(%)			0.09
1997		0.22			0				0		0		(%)			0.09
1998		0.24			0				0		0		(%)			0.12
1999		0.3			0				0		0		(%)			0.15
2000		0.36			0				0		0		(%)			0.14
2001		0.36			0				0		0		(%)			0.16
2002		0.37			0				0		0		(%)			0.18
2003		0.39			0				0		0		(%)			0.19
2004		0.4			0				0		0		(%)			0.18
2005		0.42			0				0		0		(%)			0.2
2006		0.45			0				0		0		(%)			0.19
2007		0.38			0				0		0		(%)			0.16
2008		0.39			0				0		0		(%)			0.17
2009		0.36			0				0		0		(%)			0.17
2010		0.34		2	2			1	0		0		(%)			0.15
2011		0.4		2	4			2	2		2		(%)			0.19
2012	0.25	0.44	0.25	1	5	2	0.4	2	4	1	4	1	(%)	1	1	0.2
2013	0.33	0.49	0.2	1	6	1	0.17	6	3	1	5	1	(%)			0.2
2014	0.5	0.52	0.17	2	8	1	0.13		2	1	6	1	(%)			0.23
2015		0.54		1	9				3		8		(%)			0.24
2016		0.6	0.43		9	4	0.44		3		7	3	(%)			0.27
2017		0.64	0.2		9	1	0.11		1		5	1	(%)			0.28

IF:	Impact Factor: C2Y / D2Y
AIF:	Average Impact Factor for series in RePEc in year y
IF5:	Impact Factor: C5Y / D5Y
DOC:	Number of documents published in year y
CDO:	Cumulative number of documents published until year y
CCU:	Cumulative number of citations to papers published until year y
CIF:	Cumulative impact factor
CIT:	Number of citations to papers published in year y
D2Y:	Number of articles published in y-1 plus y-2
C2Y:	Cites in y to articles published in y-1 plus y-2
D5Y:	Number of articles published in y-1 until y-5
C5Y:	Cites in y to articles published in y-1 until y-5
%SC:	Percentage of selft citations in y to articles published in y-1 plus y-2
CiY:	Cites in year y to documents published in year y
II:	Immediacy Index: CiY / Documents.
AII:	Average Immediacy Index for series in RePEc in year y

50 most cited documents in this series:

#	Year	Title	Cited
1	2013	Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold. (2013). Towse, Adrian ; Karlsberg, Sarah ; Sussex, J ; Schaffer, Karlsberg S ; Barnsley, P. In: Occasional Papers. RePEc:ohe:occpap:000106. Full description at Econpapers \|\| Download paper	6
2	1982	Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry. (1982). Hartley, K ; Maynard, A. In: Occasional Papers. RePEc:ohe:occpap:000332. Full description at Econpapers \|\| Download paper	2
3	2012	The Use of Pay-for-Performance for Drugs: Can It Improve Incentives for Innovation?. (2012). Towse, Adrian ; Puig-Peiro, R ; Garrison, L. In: Occasional Papers. RePEc:ohe:occpap:000167. Full description at Econpapers \|\| Download paper	2
4	1981	Price Comparisons of Identical Products in Japan, the United States and Europe. (1981). Reekie, W D. In: Occasional Papers. RePEc:ohe:occpap:000322. Full description at Econpapers \|\| Download paper	2
5	2010	New Drugs to Tackle Antimicrobial Resistance: EU Policy Options. (2010). Towse, Adrian ; Sharma, P. In: Occasional Papers. RePEc:ohe:occpap:000216. Full description at Econpapers \|\| Download paper	1
6	2011	Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?. (2011). Towse, Adrian ; Garau, Martina ; Danzon, Patricia. In: Occasional Papers. RePEc:ohe:occpap:000191. Full description at Econpapers \|\| Download paper	1
7	2011	Critical Review of the Quality and Competition Measures and Identification Strategies Used in Health Care Studies. (2011). Mordoh, A. In: Occasional Papers. RePEc:ohe:occpap:000171. Full description at Econpapers \|\| Download paper	1

50 most relevant documents in this series (papers most cited in the last two years)

#	Year	Title	Cited
1	2013	Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold. (2013). Towse, Adrian ; Karlsberg, Sarah ; Sussex, J ; Schaffer, Karlsberg S ; Barnsley, P. In: Occasional Papers. RePEc:ohe:occpap:000106. Full description at Econpapers \|\| Download paper	5

Citing documents used to compute impact factor 0:

Year	Title

Recent citations (cites in year: CiY)

10 most frequent citing series

#	Series	Cites
1	Monographs / Office of Health Economics	1
2	Working Paper Series / Harvard University, John F. Kennedy School of Government	1
3	PharmacoEconomics / Springer	1
4	LSE Research Online Documents on Economics / London School of Economics and Political Science, LSE Library	1
5	Working Papers CERM / CompetitivitÃ , Regole, Mercati (CERM)	1

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.